Middlesex, Massachusetts (MA) Medicines-Patent and Proprietary Companies
Featured companies
Not satisfied? Select a reason•Rate this page•Send feedback
Or try our search form or quick navigation by category and location
Whereorg has 172 results under Medicines-Patent and Proprietary Companies in Middlesex.
Narrow down the browsing criteria below to see more companies.
Other categories for location Middlesex, Massachusetts
Select a location for category Medicines-Patent and Proprietary
- Acton2
- Arlington5
- Ashland7
- Bedford1
- Belmont4
- Billerica2
- Burlington5
- Cambridge13
- Chelmsford2
- Chestnut Hill2
- Concord3
- Dracut2
- Dunstable1
- Everett1
- Framingham5
- Groton2
Quick navigation
Subcategory
City or suburb
- Acton2
- Arlington5
- Ashland7
- Bedford1
- Belmont4
- Billerica2
- Burlington5
- Cambridge13
- Chelmsford2
- Chestnut Hill2
- Concord3
- Dracut2
- Dunstable1
- Everett1
- Framingham5
- Groton2
- Holliston1
- Hudson2
- Lexington3
- Littleton2
- Lowell11
- Malden3
- Marlborough6
- Maynard2
- Medford6
- Melrose5
- Natick4
- Newton8
- Newton Center1
- Newtonville1
- North Billerica1
- North Reading2
- Pepperell3
- Reading3
- Somerville8
- Stoneham2
- Sudbury4
- Tewksbury6
- Townsend1
- Wakefield3
- Waltham11
- Watertown3
- Wayland1
- Westford3
- Wilmington3
- Winchester1
- Woburn5
Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020